Cologuard Plus is expected to be available by the end of June 2025. The original remains available and will remain on the ...

The Cologuard Classic happens this week in Tucson and 13 News has you covered for live coverage and why the event is so ...

Colonoscopies are the most effective screening tool to catch colon cancer early in the disease and even prevent it, but ...

Colorectal Cancer Awareness Month is observed annually in March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. As it has ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based genomic profiling platform with widespread use in breast ...

PR Newswire TAMPA, Fla., March 3, 2025 TAMPA, Fla., March 3, 2025 /PRNewswire/ -- Obesity Care Week (OCW) returns for its annual global campaign aimed at raising awareness, educating and advocating ...

Exact says it plans to launch three new cancer tests in 2025: Cologuard Plus, next-generation colorectal cancer screening test, Oncodetect, molecular residual disease test, and Cancerguard, ...

The company best known for its Cologuard colon cancer screening test posted a loss of $864.6 million, or $4.67 per share, on revenue of $713.4 million.

Securing FDA approval and Medicare pricing for Cologuard Plus, our next generation colon cancer screening test. Completing two studies for Oncodetect, our molecular residual disease tests.